List of Tables
Table 1. Global Treatment of Parathyroid Disease Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Treatment of Parathyroid Disease Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Treatment of Parathyroid Disease Market Competitive Situation by Manufacturers in 2024
Table 4. Global Treatment of Parathyroid Disease Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Treatment of Parathyroid Disease Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Treatment of Parathyroid Disease Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Treatment of Parathyroid Disease Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Treatment of Parathyroid Disease Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Treatment of Parathyroid Disease, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Treatment of Parathyroid Disease, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Treatment of Parathyroid Disease, Product Type & Application
Table 12. Global Key Manufacturers of Treatment of Parathyroid Disease, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Treatment of Parathyroid Disease by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Treatment of Parathyroid Disease as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Treatment of Parathyroid Disease Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Treatment of Parathyroid Disease Sales by Region (2020-2025) & (K Units)
Table 18. Global Treatment of Parathyroid Disease Sales Market Share by Region (2020-2025)
Table 19. Global Treatment of Parathyroid Disease Sales by Region (2026-2031) & (K Units)
Table 20. Global Treatment of Parathyroid Disease Sales Market Share by Region (2026-2031)
Table 21. Global Treatment of Parathyroid Disease Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Treatment of Parathyroid Disease Revenue Market Share by Region (2020-2025)
Table 23. Global Treatment of Parathyroid Disease Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Treatment of Parathyroid Disease Revenue Market Share by Region (2026-2031)
Table 25. North America Treatment of Parathyroid Disease Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Treatment of Parathyroid Disease Sales by Country (2020-2025) & (K Units)
Table 27. North America Treatment of Parathyroid Disease Sales by Country (2026-2031) & (K Units)
Table 28. North America Treatment of Parathyroid Disease Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Treatment of Parathyroid Disease Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Treatment of Parathyroid Disease Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Treatment of Parathyroid Disease Sales by Country (2020-2025) & (K Units)
Table 32. Europe Treatment of Parathyroid Disease Sales by Country (2026-2031) & (K Units)
Table 33. Europe Treatment of Parathyroid Disease Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Treatment of Parathyroid Disease Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Treatment of Parathyroid Disease Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Treatment of Parathyroid Disease Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Treatment of Parathyroid Disease Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Treatment of Parathyroid Disease Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Treatment of Parathyroid Disease Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Treatment of Parathyroid Disease Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Treatment of Parathyroid Disease Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Treatment of Parathyroid Disease Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Treatment of Parathyroid Disease Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Treatment of Parathyroid Disease Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Treatment of Parathyroid Disease Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Treatment of Parathyroid Disease Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Treatment of Parathyroid Disease Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Treatment of Parathyroid Disease Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Treatment of Parathyroid Disease Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Treatment of Parathyroid Disease Sales (K Units) by Type (2020-2025)
Table 51. Global Treatment of Parathyroid Disease Sales (K Units) by Type (2026-2031)
Table 52. Global Treatment of Parathyroid Disease Sales Market Share by Type (2020-2025)
Table 53. Global Treatment of Parathyroid Disease Sales Market Share by Type (2026-2031)
Table 54. Global Treatment of Parathyroid Disease Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Treatment of Parathyroid Disease Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Treatment of Parathyroid Disease Revenue Market Share by Type (2020-2025)
Table 57. Global Treatment of Parathyroid Disease Revenue Market Share by Type (2026-2031)
Table 58. Global Treatment of Parathyroid Disease Price (US$/Unit) by Type (2020-2025)
Table 59. Global Treatment of Parathyroid Disease Price (US$/Unit) by Type (2026-2031)
Table 60. Global Treatment of Parathyroid Disease Sales (K Units) by Application (2020-2025)
Table 61. Global Treatment of Parathyroid Disease Sales (K Units) by Application (2026-2031)
Table 62. Global Treatment of Parathyroid Disease Sales Market Share by Application (2020-2025)
Table 63. Global Treatment of Parathyroid Disease Sales Market Share by Application (2026-2031)
Table 64. Global Treatment of Parathyroid Disease Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Treatment of Parathyroid Disease Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Treatment of Parathyroid Disease Revenue Market Share by Application (2020-2025)
Table 67. Global Treatment of Parathyroid Disease Revenue Market Share by Application (2026-2031)
Table 68. Global Treatment of Parathyroid Disease Price (US$/Unit) by Application (2020-2025)
Table 69. Global Treatment of Parathyroid Disease Price (US$/Unit) by Application (2026-2031)
Table 70. CTTQ Company Information
Table 71. CTTQ Description and Business Overview
Table 72. CTTQ Treatment of Parathyroid Disease Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. CTTQ Treatment of Parathyroid Disease Product
Table 74. CTTQ Recent Developments/Updates
Table 75. Roche Company Information
Table 76. Roche Description and Business Overview
Table 77. Roche Treatment of Parathyroid Disease Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. Roche Treatment of Parathyroid Disease Product
Table 79. Roche Recent Developments/Updates
Table 80. Future Health Pharma Company Information
Table 81. Future Health Pharma Description and Business Overview
Table 82. Future Health Pharma Treatment of Parathyroid Disease Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. Future Health Pharma Treatment of Parathyroid Disease Product
Table 84. Future Health Pharma Recent Developments/Updates
Table 85. KPC Pharmaceuticals Company Information
Table 86. KPC Pharmaceuticals Description and Business Overview
Table 87. KPC Pharmaceuticals Treatment of Parathyroid Disease Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. KPC Pharmaceuticals Treatment of Parathyroid Disease Product
Table 89. KPC Pharmaceuticals Recent Developments/Updates
Table 90. Teva Pharmaceutical Company Information
Table 91. Teva Pharmaceutical Description and Business Overview
Table 92. Teva Pharmaceutical Treatment of Parathyroid Disease Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. Teva Pharmaceutical Treatment of Parathyroid Disease Product
Table 94. Teva Pharmaceutical Recent Developments/Updates
Table 95. Nantong Huashan Pharmaceutical Company Information
Table 96. Nantong Huashan Pharmaceutical Description and Business Overview
Table 97. Nantong Huashan Pharmaceutical Treatment of Parathyroid Disease Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. Nantong Huashan Pharmaceutical Treatment of Parathyroid Disease Product
Table 99. Nantong Huashan Pharmaceutical Recent Developments/Updates
Table 100. Teijin Pharma Company Information
Table 101. Teijin Pharma Description and Business Overview
Table 102. Teijin Pharma Treatment of Parathyroid Disease Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. Teijin Pharma Treatment of Parathyroid Disease Product
Table 104. Teijin Pharma Recent Developments/Updates
Table 105. Kyowa Kirin Company Information
Table 106. Kyowa Kirin Description and Business Overview
Table 107. Kyowa Kirin Treatment of Parathyroid Disease Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. Kyowa Kirin Treatment of Parathyroid Disease Product
Table 109. Kyowa Kirin Recent Developments/Updates
Table 110. Cheplapharm Arzneimittel Company Information
Table 111. Cheplapharm Arzneimittel Description and Business Overview
Table 112. Cheplapharm Arzneimittel Treatment of Parathyroid Disease Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 113. Cheplapharm Arzneimittel Treatment of Parathyroid Disease Product
Table 114. Cheplapharm Arzneimittel Recent Developments/Updates
Table 115. Jiangsu Hengrui Pharmaceuticals Company Information
Table 116. Jiangsu Hengrui Pharmaceuticals Description and Business Overview
Table 117. Jiangsu Hengrui Pharmaceuticals Treatment of Parathyroid Disease Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 118. Jiangsu Hengrui Pharmaceuticals Treatment of Parathyroid Disease Product
Table 119. Jiangsu Hengrui Pharmaceuticals Recent Developments/Updates
Table 120. Novartis Company Information
Table 121. Novartis Description and Business Overview
Table 122. Novartis Treatment of Parathyroid Disease Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 123. Novartis Treatment of Parathyroid Disease Product
Table 124. Novartis Recent Developments/Updates
Table 125. Chongqing Yaoyou Pharmaceutical Company Information
Table 126. Chongqing Yaoyou Pharmaceutical Description and Business Overview
Table 127. Chongqing Yaoyou Pharmaceutical Treatment of Parathyroid Disease Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 128. Chongqing Yaoyou Pharmaceutical Treatment of Parathyroid Disease Product
Table 129. Chongqing Yaoyou Pharmaceutical Recent Developments/Updates
Table 130. AbbVie Company Information
Table 131. AbbVie Description and Business Overview
Table 132. AbbVie Treatment of Parathyroid Disease Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 133. AbbVie Treatment of Parathyroid Disease Product
Table 134. AbbVie Recent Developments/Updates
Table 135. Hebei Renhe Yikang Pharmaceutical Company Information
Table 136. Hebei Renhe Yikang Pharmaceutical Description and Business Overview
Table 137. Hebei Renhe Yikang Pharmaceutical Treatment of Parathyroid Disease Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 138. Hebei Renhe Yikang Pharmaceutical Treatment of Parathyroid Disease Product
Table 139. Hebei Renhe Yikang Pharmaceutical Recent Developments/Updates
Table 140. Key Raw Materials Lists
Table 141. Raw Materials Key Suppliers Lists
Table 142. Treatment of Parathyroid Disease Distributors List
Table 143. Treatment of Parathyroid Disease Customers List
Table 144. Treatment of Parathyroid Disease Market Trends
Table 145. Treatment of Parathyroid Disease Market Drivers
Table 146. Treatment of Parathyroid Disease Market Challenges
Table 147. Treatment of Parathyroid Disease Market Restraints
Table 148. Research Programs/Design for This Report
Table 149. Key Data Information from Secondary Sources
Table 150. Key Data Information from Primary Sources
Table 151. Authors List of This Report
List of Figures
Figure 1. Product Picture of Treatment of Parathyroid Disease
Figure 2. Global Treatment of Parathyroid Disease Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Treatment of Parathyroid Disease Market Share by Type: 2024 & 2031
Figure 4. Calcitriol Product Picture
Figure 5. Alfacalcidol Product Picture
Figure 6. Salmon Calcitonin Product Picture
Figure 7. Paricalcitol Product Picture
Figure 8. Other Product Picture
Figure 9. Global Treatment of Parathyroid Disease Market Value by Application (2020-2031) & (US$ Million)
Figure 10. Global Treatment of Parathyroid Disease Market Share by Application: 2024 & 2031
Figure 11. Hospital
Figure 12. Clinic
Figure 13. Other
Figure 14. Global Treatment of Parathyroid Disease Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Treatment of Parathyroid Disease Market Size (2020-2031) & (US$ Million)
Figure 16. Global Treatment of Parathyroid Disease Sales (2020-2031) & (K Units)
Figure 17. Global Treatment of Parathyroid Disease Average Price (US$/Unit) & (2020-2031)
Figure 18. Treatment of Parathyroid Disease Report Years Considered
Figure 19. Treatment of Parathyroid Disease Sales Share by Manufacturers in 2024
Figure 20. Global Treatment of Parathyroid Disease Revenue Share by Manufacturers in 2024
Figure 21. Global 5 and 10 Largest Treatment of Parathyroid Disease Players: Market Share by Revenue in Treatment of Parathyroid Disease in 2024
Figure 22. Treatment of Parathyroid Disease Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 23. Global Treatment of Parathyroid Disease Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 24. North America Treatment of Parathyroid Disease Sales Market Share by Country (2020-2031)
Figure 25. North America Treatment of Parathyroid Disease Revenue Market Share by Country (2020-2031)
Figure 26. United States Treatment of Parathyroid Disease Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 27. Canada Treatment of Parathyroid Disease Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. Europe Treatment of Parathyroid Disease Sales Market Share by Country (2020-2031)
Figure 29. Europe Treatment of Parathyroid Disease Revenue Market Share by Country (2020-2031)
Figure 30. Germany Treatment of Parathyroid Disease Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. France Treatment of Parathyroid Disease Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. U.K. Treatment of Parathyroid Disease Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. Italy Treatment of Parathyroid Disease Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Russia Treatment of Parathyroid Disease Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Asia Pacific Treatment of Parathyroid Disease Sales Market Share by Region (2020-2031)
Figure 36. Asia Pacific Treatment of Parathyroid Disease Revenue Market Share by Region (2020-2031)
Figure 37. China Treatment of Parathyroid Disease Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. Japan Treatment of Parathyroid Disease Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. South Korea Treatment of Parathyroid Disease Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. India Treatment of Parathyroid Disease Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Australia Treatment of Parathyroid Disease Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. China Taiwan Treatment of Parathyroid Disease Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Southeast Asia Treatment of Parathyroid Disease Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Latin America Treatment of Parathyroid Disease Sales Market Share by Country (2020-2031)
Figure 45. Latin America Treatment of Parathyroid Disease Revenue Market Share by Country (2020-2031)
Figure 46. Mexico Treatment of Parathyroid Disease Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Brazil Treatment of Parathyroid Disease Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Argentina Treatment of Parathyroid Disease Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Middle East and Africa Treatment of Parathyroid Disease Sales Market Share by Country (2020-2031)
Figure 50. Middle East and Africa Treatment of Parathyroid Disease Revenue Market Share by Country (2020-2031)
Figure 51. Turkey Treatment of Parathyroid Disease Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Saudi Arabia Treatment of Parathyroid Disease Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. UAE Treatment of Parathyroid Disease Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 54. Global Sales Market Share of Treatment of Parathyroid Disease by Type (2020-2031)
Figure 55. Global Revenue Market Share of Treatment of Parathyroid Disease by Type (2020-2031)
Figure 56. Global Treatment of Parathyroid Disease Price (US$/Unit) by Type (2020-2031)
Figure 57. Global Sales Market Share of Treatment of Parathyroid Disease by Application (2020-2031)
Figure 58. Global Revenue Market Share of Treatment of Parathyroid Disease by Application (2020-2031)
Figure 59. Global Treatment of Parathyroid Disease Price (US$/Unit) by Application (2020-2031)
Figure 60. Treatment of Parathyroid Disease Value Chain
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
